Trial Profile
Open-label Follow-up Study to Investigate the Seropersistence of TBE Antibodies and the Booster Response to a Tick-borne Encephalitis Vaccine in Children and Adolescents Aged 3 - 18 Years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis; Encephalitis virus infections
- Focus Pharmacodynamics
- Sponsors Pfizer
- 14 Jul 2016 New trial record